Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
CRYAB modulates the activation of CD4+ T cells from relapsing-remitting multiple sclerosis patients.
Electrophysiological markers and predictors of the disease course in primary progressive multiple sclerosis.
[Fingolimod compassionate use program : Case study on the concept of a therapy option for multiple sclerosis prior to marketing approval.]
Dalfampridine prior authorization program: a cohort study.
Acute disseminated encephalomyelitis, transverse myelitis, and neuromyelitis optica.
Leukemia inhibitory factor inhibits T helper 17 cell differentiation and confers treatment effects of neural progenitor cell therapy in autoimmune disease.
Second generation S1P pathway modulators: Research strategies and clinical developments.
Role of iNOS-NO-cGMP signaling in modulation of inflammatory and myelination processes.
Polypharmacy in multiple sclerosis: Relationship with fatigue, perceived cognition, and objective cognitive performance.
Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders.
Affinity Proteomic Profiling of Plasma, Cerebrospinal Fluid, and Brain Tissue within Multiple Sclerosis.
Enhanced Action Potential Passage Through the Node of Ranvier of Myelinated Axons via Proton Hopping.
The risks for falls and fractures in multiple sclerosis.
Differences in oligoclonal bands and visual evoked potentials in patients with radiologically and clinically isolated syndrome.
The effect of ribavirin on reactive astrogliosis in experimental autoimmune encephalomyelitis.
Elevated Lipid Profiles in Patients with Acute Transverse Myelitis.
Enhanced remyelination following lysolecithin-induced demyelination in mice under treatment with fingolimod (FTY720).
Vitamin D in clinically isolated syndrome: evidence for possible neuroprotection.
Disruption of nodal architecture in skin biopsies of patients with demyelinating neuropathies.
[Clinically isolated syndrome.]
Neuregulin and BDNF Induce a Switch to NMDA Receptor-Dependent Myelination by Oligodendrocytes.
Impaired adult myelination in the prefrontal cortex of socially isolated mice.
Epstein Barr virus infection reactivation as a possible trigger of primary biliary cirrhosis-like syndrome in a patient with multiple sclerosis in the course of fingolimod treatment.
A clinical and radiological profile of neuromyelitis optica and spectrum disorders in an Indian cohort.
2-Deoxy-d-glucose attenuates sevoflurane-induced neuroinflammation through nuclear factor-kappa B pathway in vitro.
Pages
« first
‹ previous
…
302
303
304
305
306
307
308
309
310
…
next ›
last »